- Offers a clinically relevant resource grounded in the latest research
- Applies an evidence-based approach to all aspects of implant dentistry, including maxillofacial prosthodontics, from planning to surgery and restoration
- Describes procedures in detail with accompanying images
- Covers all stages of treatment, from planning to execution
- Includes access to a companion website with video clips demonstrating procedures and the figures from the book in PowerPoint
Steven J. Sadowsky is Professor and Director of Implant Education, University of the Pacific, Arthur A. Dugoni School of Dentistry in San Francisco, California, USA.
Steven J. Sadowsky is Professor and Director of Implant Education, University of the Pacific, Arthur A. Dugoni School of Dentistry in San Francisco, California, USA.
Contributors, vi
Foreword, viii
Prologue, ix
Acknowledgments, xi
About the Companion Website, xii
1 The State of the Evidence in Implant Prosthodontics, 1
Gary R. Goldstein
2 Systemic Factors Influencing Dental Implant Therapy, 11
Steven J. Sadowsky
3 Maintenance Considerations in Treatment Planning Implant Restorations, 22
Donald A. Curtis, Hamilton Le, and Roy T. Yanase
4 Three-Dimensional Radiographic Imaging for Implant Positioning, 36
Anders Nattestad
5 Decision Making in Bone Augmentation to Optimize Dental Implant Therapy, 46
Jaime L. Lozada, Istvan Urban, and Joseph Y.K. Kan
6 Immediate Implant Placement and Provisionalization of Maxillary Anterior Single Implants, 57
Joseph Y.K. Kan, Kitichai Rungcharassaeng, and Jaime L. Lozada
7 Surgical Complications in Implant Placement, 67
Paul B. Greenawalt
8 Failure in Osseointegration, 77
Kumar C. Shah, S. Andrew Chapokas, and Sreenivas Koka
9 Implant Restoration of the Partially Edentulous Patient, 85
Steven J. Sadowsky
10 Prosthodontic Considerations in the Implant Restoration of the Esthetic Zone, 109
Ghadeer Thalji and Sandra Al-Tarawneh
11 Ceramic Materials in Implant Dentistry, 123
Parag R. Kachalia
12 Cement-Retained Implant Restorations: Problems and Solutions, 134
Chandur P.K. Wadhwani
13 Implant Restoration of the Growing Patient, 159
Clark M. Stanford
14 Occlusion: the Role in Implant Prosthodontics, 169
Avinash S. Bidra and Thomas D. Taylor
15 Evolving Technologies in Implant Prosthodontics, 184
David G. Gratton
16 Implant Dentistry: Challenges in the Treatment of the Edentulous Patient, 207
Steven J. Sadowsky, Howard M. Landesman, and W. Peter Hansen
17 Implant Restoration of the Maxillary Edentulous Patient, 221
Nicola U. Zitzmann
18 Implant Restoration of the Mandibular Edentulous Patient, 241
Steven J. Sadowsky
19 Material Considerations in the Fabrication of Prostheses for Completely Edentulous Patients, 269
James A. Kelly and Thomas J. Salinas
20 Digital Alternatives in the Implant Restoration of the Edentulous Patient, 293
Mathew T. Kattadiyil
21 Restoration of Acquired Oral Defects with Osseointegrated Implants, 302
John Beumer, III, Karl Lyons, Jay Jayanetti, and Eric C. Sung
22 Implant-Retained Restoration of the Craniofacial Patient, 325
Robert Ferguson Wright, Glenn E. Minsley, and Sun-Yung Bak
23 Peri-Implant Diseases, 349
Brian Kucey and Elena Hernandez-Kucey
Epilogue, 377
Index, 379
"This book is well written and organized. The approach is evidence based, with the majority of the focus on treatment planning for implants in patients who are partially or completely edentulous. The pairing of the book with the website is very helpful to visual learners and those who have limited experience with implant placement." (Doody Enterprises 28/04/2017)
CHAPTER 1
The State of the Evidence in Implant Prosthodontics
Gary R. Goldstein
New York University College of Dentistry, New York, New York, USA
Introduction
Okay, you have been placing and/or restoring implants for numerous years and are pleased with your clinical outcomes and your patient acceptance of this exciting treatment modality. You attend a lecture or read an article about a new product or technique that claims to have a higher insertion torque, less bone loss, etc.; so, how do you decide if you should switch? The rubrics are very simple, so, whether you read a paper in a peer‐reviewed journal, a non‐peer‐reviewed journal, or hear it in a lecture, the rules are the same for all three.
There is a multitude of information available to the clinician, some evidence‐based, some theory‐based, some compelling and, unfortunately, some useless. Evidence‐based dentistry (EBD) gives one the tools to evaluate the literature and scientific presentations. It constructs a hierarchy of evidence which allows the reader to put what they are reading, or hearing, into perspective. As we proceed on this short trail together, I want to state that there is no substitute for your own clinical experience and common sense, and hope that when you are done with this chapter you will understand why. I am not here to trash the literature, rather to propose that not all published works are equal.
Hierarchy of evidence
EBD is a relatively new phenomenon that was introduced in the 1990s. It evolved slowly due to misunderstandings and misrepresentations of what it is and what it means, and, despite a slow start, has picked up traction and is now an ADA Commission on Dental Accreditation (CODA) requirement, mandatory in dental education and the backbone of clinical research and practice. Journal editors and reviewers are well versed in the process and less likely to approve the methodologically flawed project for publication, putting more pressure on the researcher to pay heed to research design.
I could say, “Here is the hierarchy of evidence (Figure 1.1),” and save us, you the reader and me the author, a lot of time, but unfortunately things are not quite that simple. Routinely, if one is asked what the best evidence is, the response would be a meta‐analysis or systematic review and, not having that, a randomized controlled trial (RCT). What is also obvious from the figure is the categorization of animal and laboratory studies. While these present critical contributions to our basic knowledge and the background information needed to design clinical studies, they cannot and should not be utilized to make clinical decisions.
Figure 1.1 Hierarchy of evidence.
Source: Adapted from http://consumers.cochrane.org.
According to the Cochrane Collaboration,1 a Systematic Review (SR) “summarises the results of available carefully designed healthcare studies (controlled trials) and provides a high level of evidence on the effectiveness of healthcare interventions”; and a meta‐analysis (MA) is a SR where the authors pool numerical data. I want to bring your attention to the fact that nowhere in the definition does it mention, or limit itself to, RCTs. SRs and MAs are different from the more typical narrative review where an investigator evaluates all, or much, of the available literature and tenders an “expert opinion” of the results. They usually have loose or no inclusion and exclusion criteria and no “ranking” of the articles being reviewed. For those interested in how one categorizes articles, the following websites would be helpful:
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891443/
- http://www.nature.com/ebd/journal/v10/n1/fig_tab/6400636f1.html#figure‐title
- http://www.ebnp.co.uk/The%20Hierarchy%20of%20Evidence.htm
We can break down studies into analytic or comparative, those that have a comparative group (randomized controlled trials, concurrent cohort studies, and case control studies) and descriptive, those that do not have a comparative group (cross‐sectional surveys, case series, and case reports). Descriptive studies give us useful information about a material, treatment, etc., however, to determine if one material, treatment, etc. is better than another, requires a comparative study.
In addition, studies may be prospective or retrospective. In a prospective study the investigator selects one or more groups (cohorts) and follows them forward in time. In a retrospective study the investigator selects one or more cohorts and looks backwards in time. Prospective studies are considered superior since they can ensure that the cohorts were similar for possible confounding variables at the beginning of the study, that all participants were treated equally, and that dropouts are known and accounted for. Prospective studies allow for randomization or prognostic stratification of the cohorts. Retrospective studies can be very valuable and should not be minimalized, especially in uncovering adverse outcomes that have a low prevalence or take many years to become evident. The adverse effects from smoking have mostly been uncovered by retrospective investigation.
A randomized controlled trial (RCT) is a prospective, comparative study in which the assignment to the treatment or control group is done using a process analogous to flipping a coin. In reality, most projects are randomized utilizing a computer‐generated random assignment protocol. The sole advantage of randomization is that it eliminates allocation bias. Feinstein2 and Brunette3 feel that the universal dependence on RCTs to achieve this is overestimated and prefer prognostic stratification of the matched cohorts for major confounding variables prior to allocation. What soon becomes obvious, however, is that prognostic stratification is not possible for every potential confounding variable, so only “major” ones are usually accounted for.
Doing an RCT is ideal, but has the constraints of time (can we afford to wait the numerous years necessary to design, implement and publish?) and cost (where can you get the funding?). Furthermore, RCTs are only ideal for certain questions, for example one that involves therapy. If our question is one of harm, it would be unethical to randomize a patient to something with a known harmful effect. To my knowledge, there has never been a RCT that proved smoking was harmful. Could you get an Internal Review Board (IRB) or Ethics Committee approval to assign participants to a group that had to smoke two packs of cigarettes a day for 25 years? Yet, does anyone doubt, given the mass of clinical evidence, that it is better to not smoke? Ultimately, the design is determined by the question.
Sackett,4 considered by many to be the father of evidence‐based medicine, in response to the heated dialogue over which design was the best, and in an effort to refocus the time, intellect, energy, and effort being wasted, proposed that “the question being asked determines the appropriate research architecture, strategy, and tactics to be used – not tradition, authority, experts, paradigms, or schools of thought.”
Causation is one of the most difficult things to prove. It is like approaching a single set of railroad tracks. One can feel the warmth of the track and know that a train passed, but in which direction? It is why many studies conclude a “correlation.” In the EBM series authored by the McMaster faculty, the Causation section published in the Canadian Medical Journal had David Sackett using the pseudonym Prof. Kilgore Trout as the corresponding author.5 One can only wonder what motivated him to use the pseudonym rather than his own name to write on this critical topic. Sackett’s love of the works of Kurt Vonnegut is well known and one might wonder if, in fact, his Canadian home named the Trout Research & Education Centre, is based on Kilgore or the fish?
While the design is critical, one must also determine the validity of the methodology. According to Jacob and Carr,6 internal validity is a reflection of how the study was planned and carried out and is threatened by bias and random variation; while external validity defines if the results of the study will be applicable in other clinical settings.
Bias
There are many types of biases and a full explanation of the multitude reported is beyond the scope of this chapter. Still, there are a few that are meaningful to us as clinicians. We can divide bias into the following groups: the reader, the author, and the journal.
The reader
Taleb7 used the following quote to accent that past experience is not always the best method to judge what we are doing at the present time.
But in all my experience, I have never been in an accident…of any sort worth speaking about. I have seen but one vessel in distress in all my years at sea. I never saw a wreck and have never been wrecked nor was I ever in any predicament that threatened to end in disaster of any sort.
E.J. Smith, 1907, Captain RMS Titanic.
The reader is almost always subject to confirmation bias, which is to believe whatever confirms one’s beliefs. It was best stated by Sir Francis Bacon8 : “The human understanding, once it has adopted an opinion, collects any instances that confirm it, and though the contrary instances may be more numerous and more weighty, it either does not notice them...
| Erscheint lt. Verlag | 21.11.2016 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
| Medizin / Pharmazie ► Medizinische Fachgebiete | |
| Medizin / Pharmazie ► Zahnmedizin | |
| Schlagworte | dentistry • Implant Dentistry • Implantologie • Implantologie i. d. Zahnheilkunde • <p>Evidence-based, systematic reviews, clinical trials, research, decision making, implant, restorative, prosthodontics, osseointegration, bone augmentation, treatment, maintenance, care, partially edentulous, completely edentulous, materials, peri-implant diseases, maxillofacial, dental, dentistry</p> • Parodontologie • Periodontology • Prosthodontics • Zahnmedizin • Zahnprothesen |
| ISBN-13 | 9781119080008 / 9781119080008 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich